These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
433 related items for PubMed ID: 9521938
1. Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia. Therrell BL, Berenbaum SA, Manter-Kapanke V, Simmank J, Korman K, Prentice L, Gonzalez J, Gunn S. Pediatrics; 1998 Apr; 101(4 Pt 1):583-90. PubMed ID: 9521938 [Abstract] [Full Text] [Related]
4. Neonatal screening for congenital adrenal hyperplasia in Southern Brazil: a population based study with 108,409 infants. Kopacek C, de Castro SM, Prado MJ, da Silva CM, Beltrão LA, Spritzer PM. BMC Pediatr; 2017 Jan 17; 17(1):22. PubMed ID: 28095810 [Abstract] [Full Text] [Related]
5. Congenital adrenal hyperplasia cases identified by newborn screening in one- and two-screen states. Held PK, Shapira SK, Hinton CF, Jones E, Hannon WH, Ojodu J. Mol Genet Metab; 2015 Nov 17; 116(3):133-8. PubMed ID: 26296712 [Abstract] [Full Text] [Related]
6. A comparative cost analysis of newborn screening for classic congenital adrenal hyperplasia in Texas. Brosnan CA, Brosnan P, Therrell BL, Slater CH, Swint JM, Annegers JF, Riley WJ. Public Health Rep; 1998 Nov 17; 113(2):170-8. PubMed ID: 9719819 [Abstract] [Full Text] [Related]
10. Benefits of neonatal screening for congenital adrenal hyperplasia (21-hydroxylase deficiency) in Sweden. Thil'en A, Nordenström A, Hagenfeldt L, von Döbeln U, Guthenberg C, Larsson A. Pediatrics; 1998 Apr 17; 101(4):E11. PubMed ID: 9521977 [Abstract] [Full Text] [Related]
11. Neonatal Screening for Congenital Adrenal Hyperplasia in Turkey: A Pilot Study with 38,935 Infants. Güran T, Tezel B, Gürbüz F, Selver Eklioğlu B, Hatipoğlu N, Kara C, Şimşek E, Çizmecioğlu FM, Ozon A, Baş F, Aydın M, Darendeliler F. J Clin Res Pediatr Endocrinol; 2019 Feb 20; 11(1):13-23. PubMed ID: 30111524 [Abstract] [Full Text] [Related]
12. A pilot study on newborn screening for congenital adrenal hyperplasia in Beijing. Gong LF, Gao X, Yang N, Zhao JQ, Yang HH, Kong YY. J Pediatr Endocrinol Metab; 2019 Mar 26; 32(3):253-258. PubMed ID: 30817302 [Abstract] [Full Text] [Related]
13. Outcome of Newborn Screening for Congenital Adrenal Hyperplasia at Two Time Points. Eshragh N, Doan LV, Connelly KJ, Denniston S, Willis S, LaFranchi SH. Horm Res Paediatr; 2020 Mar 26; 93(2):128-136. PubMed ID: 32659761 [Abstract] [Full Text] [Related]
15. Neonatal screening for congenital adrenal hyperplasia: 17-hydroxyprogesterone levels and CYP21 genotypes in preterm infants. Nordenström A, Wedell A, Hagenfeldt L, Marcus C, Larsson A. Pediatrics; 2001 Oct 26; 108(4):E68. PubMed ID: 11581476 [Abstract] [Full Text] [Related]
16. [Congenital adrenal hyperplasia]. Stanić M, Nesović M. Med Pregl; 1999 Oct 26; 52(11-12):447-54. PubMed ID: 10748766 [Abstract] [Full Text] [Related]